Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.45 USD | -2.76% | -2.09% | +5.36% |
12:48pm | RBC Trims Price Target on Bausch Health to $11 From $12, Keeps Sector Perform Rating | MT |
Apr. 22 | RBC Cuts Bausch + Lomb Target to US$18, Reiterates Outperform, as Previews Q1 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.36% | 3.1B | |
+25.46% | 659B | |
+26.72% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.19% | 215B | |
+7.34% | 210B | |
-6.01% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- BHC Stock
- News Bausch Health Companies Inc.
- Bausch Health Posts Q2 Revenue US$1.967 Billion; Lowers 2022 Guidance